SEC Form 4 · accession 0001179110-15-016067
MADRIGAL PHARMACEUTICALS, INC. · MDGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Keith R Gollust
Director
Period of report
Dec 7, 2015
Accepted (ET)
Dec 9, 2015 · 5:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157601
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 7, 2015 | S | 300,000 | $0.3861 | D | 2,585,061 | I | By Wyandanch Partners, L.P. |
| Common StockF3,F2 | Dec 8, 2015 | S | 300,000 | $0.3802 | D | 2,285,061 | I | By Wyandanch Partners, L.P. |
| Common StockF4,F2 | Dec 9, 2015 | S | 145,892 | $0.3786 | D | 2,139,169 | I | By Wyandanch Partners, L.P. |
| Common Stock | holding | — | — | — | 401,764 | D | ||
| Common Stock | holding | — | — | — | 175,000 | I | By Keith R. Gollust IRA |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $0.38 to $0.395 per share. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F3This transaction was executed in multiple trades at prices ranging from $0.3617 to $0.3998 per share. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $0.37 to $0.3839 per share. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.